Correction: CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion

• Joris van de Haar,
• Louisa Hoes,
• Emile Voest

Affiliations

Joris van de Haar

Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Louisa Hoes

Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Emile Voest

Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands